Georgiamune is a pioneering biotechnology firm focused on reprogramming immune responses. By regulating signaling pathways, the company aims to restore immune homeostasis, addressing critical challenges in cancer and autoimmune diseases to advance therapeutic solutions in the life sciences sector.